Ana Echarri

1.2k total citations
51 papers, 452 citations indexed

About

Ana Echarri is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Ana Echarri has authored 51 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 26 papers in Surgery and 26 papers in Epidemiology. Recurrent topics in Ana Echarri's work include Inflammatory Bowel Disease (34 papers), Microscopic Colitis (21 papers) and Eosinophilic Esophagitis (11 papers). Ana Echarri is often cited by papers focused on Inflammatory Bowel Disease (34 papers), Microscopic Colitis (21 papers) and Eosinophilic Esophagitis (11 papers). Ana Echarri collaborates with scholars based in Spain, United States and Portugal. Ana Echarri's co-authors include Manuel Barreiro‐de Acosta, Daniel Carpio, Santos Pereira, Aurelio Lorenzo, María Chaparro, Pilar Nos, Iván Guerra, Javier P. Gisbert, Eugeni Domènech and Mariam Aguas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ana Echarri

45 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Echarri Spain 13 320 266 172 74 38 51 452
Mark Lust Australia 12 198 0.6× 158 0.6× 131 0.8× 49 0.7× 50 1.3× 29 326
Jordi Gordillo Spain 16 470 1.5× 404 1.5× 227 1.3× 66 0.9× 109 2.9× 46 701
Alfonso Martínez United States 5 399 1.2× 306 1.2× 202 1.2× 63 0.9× 113 3.0× 10 612
Arun Gupta India 9 152 0.5× 102 0.4× 284 1.7× 34 0.5× 15 0.4× 31 429
Rishi Bolia India 13 66 0.2× 125 0.5× 187 1.1× 38 0.5× 32 0.8× 63 361
Liliana Andrade Chebli Brazil 12 218 0.7× 174 0.7× 204 1.2× 52 0.7× 28 0.7× 36 464
Yoon‐Kyo An Australia 9 224 0.7× 179 0.7× 140 0.8× 53 0.7× 53 1.4× 24 329
V Chhaya United Kingdom 13 226 0.7× 208 0.8× 135 0.8× 37 0.5× 16 0.4× 25 334
Dhiman Basu United States 5 138 0.4× 157 0.6× 58 0.3× 28 0.4× 77 2.0× 7 304
Pedro Duarte Gaburri Brazil 12 183 0.6× 161 0.6× 235 1.4× 47 0.6× 15 0.4× 28 435

Countries citing papers authored by Ana Echarri

Since Specialization
Citations

This map shows the geographic impact of Ana Echarri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Echarri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Echarri more than expected).

Fields of papers citing papers by Ana Echarri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Echarri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Echarri. The network helps show where Ana Echarri may publish in the future.

Co-authorship network of co-authors of Ana Echarri

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Echarri. A scholar is included among the top collaborators of Ana Echarri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Echarri. Ana Echarri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Altieri, Barbara, et al.. (2026). International real-world study on osilodrostat efficacy and safety in adrenal Cushing syndrome. The Journal of Clinical Endocrinology & Metabolism. 1 indexed citations
2.
Aguas, Mariam, Ana Echarri, Marta Calvo, et al.. (2025). Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis on the use of Telemedicine in Inflammatory Bowel Disease. Gastroenterología y Hepatología (English Edition). 48(6). 502320–502320.
3.
4.
Carrascosa, J.M., Ana Echarri, Paloma García de la Peña, et al.. (2024). Contraceptive Recommendations for Women with Immune-Mediated Inflammatory Diseases: A Delphi Consensus. Advances in Therapy. 41(4). 1372–1384. 1 indexed citations
5.
6.
Echarri, Ana, José Lázaro Pérez‐Calle, Marta Calvo, et al.. (2022). Should Inflammatory Bowel Disease Clinicians Provide Their Patients with e-Health Resources? Patients' and Professionals' Perspectives. Telemedicine Journal and e-Health. 29(10). 1504–1513. 5 indexed citations
7.
Sicilia, Beatriz, Raquel Vicente, Lara Arias, et al.. (2021). Recommendations of the Spanish Working Group on Crohn’s disease and Ulcerative Colitis (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa — GETECCU) on dysplasia screening in inflammatory bowel disease patients. Gastroenterología y Hepatología (English Edition). 44(6). 435–447. 1 indexed citations
8.
9.
Echarri, Ana, Isabel Vera, C Aràjol, et al.. (2019). The Harvey–Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study. Telemedicine Journal and e-Health. 26(1). 78–86. 21 indexed citations
10.
Echarri, Ana, et al.. (2017). Síndrome de Susac en un paciente con colitis ulcerosa. Gaceta Médica de México. 153(7). 924–927. 1 indexed citations
11.
Echarri, Ana, et al.. (2015). Impact of postinduction infliximab trough level and disease activity on primary response in Crohn's Disease. Lithuanian University of Health Sciences. 9. 5 indexed citations
12.
Cerrillo, Elena, et al.. (2015). Fecal Calprotectin in Ileal Crohnʼs Disease. Inflammatory Bowel Diseases. 21(7). 1572–1579. 54 indexed citations
13.
Carpio, Daniel, et al.. (2015). Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain. European Journal of Gastroenterology & Hepatology. 27(9). 1030–1037. 9 indexed citations
14.
Acosta, Manuel Barreiro‐de, Ana Echarri, Daniel Carpio, et al.. (2011). A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.. PubMed. 20(3). 247–53. 37 indexed citations
15.
Echarri, Ana, et al.. (2010). Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure. Journal of Crohn s and Colitis. 4(6). 654–660. 27 indexed citations
16.
17.
Santos‐García, Diego, et al.. (2010). Experience with continuous levodopa enteral infusion (Duodopa®)in patients with advanced Parkinson's disease in a secondary level hospital. SHILAP Revista de lepidopterología. 25(9). 536–543. 11 indexed citations
18.
Echarri, Ana, et al.. (2010). Ileal Crohn's disease: MRI with endoscopic correlation. European Journal of Radiology. 80(2). e8–e12. 32 indexed citations
19.
Magro, Fernando, Manuel Barreiro‐de Acosta, Paula Lago, et al.. (2010). Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events. Journal of Crohn s and Colitis. 4(3). 301–311. 7 indexed citations
20.
Cubiella, Joaquín, et al.. (2005). Sedation at Endoscopic Units in Galicia: results of the "Sociedad Gallega de Patología Digestiva" inquiry. Revista Española de Enfermedades Digestivas. 97(1). 24–37. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Lust Breakdown of academic impact, for papers by Jordi Gordillo Breakdown of academic impact, for papers by Alfonso Martínez Breakdown of academic impact, for papers by Arun Gupta Breakdown of academic impact, for papers by Rishi Bolia Breakdown of academic impact, for papers by Liliana Andrade Chebli Breakdown of academic impact, for papers by Yoon‐Kyo An Breakdown of academic impact, for papers by V Chhaya Breakdown of academic impact, for papers by Dhiman Basu Breakdown of academic impact, for papers by Pedro Duarte Gaburri
Rankless by CCL
2026